Alexis Borisy (Han jingyu/Imaginechina via AP Images)

Up­dat­ed: EQRx sells it­self to an­oth­er Alex­is Borisy com­pa­ny, Rev­o­lu­tion Med­i­cines, in all-stock deal

The end of EQRx has of­fi­cial­ly ar­rived.

EQRx will be ac­quired by Rev­o­lu­tion Med­i­cines in an all-stock trans­ac­tion, the com­pa­nies an­nounced Tues­day morn­ing

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.